… Like the primary STAR*D study, we examined initial citalopram treatment (level 1) among
2876 … responders to citalopram treatment were eligible for randomization to level 2 treatments, …

… We applied ROC analysis to data from the first treatment … patients and treated them for 8–14
weeks with citalopram in real… after citalopram treatment (both response and remission) using …

… of treatment with citalopram. Additionally, some prior reports of residual fatigue included
responders without remission … The emergence of suicidal ideation with antidepressant treatment …

… risk for non reaching remission of depressive episode after citalopram treatment than patients
… clinical remission of major depressive episodes after twelve weeks of citalopram treatment. …

… In this study, we sought to identify possible biomarkers predicting remission to citalopram,
we conducted a study in a sample comp rising 77 untreated MDD outpatients analyzing …

… if common DNA variation influences citalopram response and remission. … citalopram dose.
Our findings may be specific to citalopram treatment and may not be the same for treatment …

… by symptoms, evaluate sex differences in and examine correlates of these subtypes, and
examine the association between subtype and symptom remission after citalopram treatment. …

… to switch to citalopram (desipramine-citalopram). There were … the four treatment groups:
five on citalopram-citalopram, one on … Remission rates differed between switched (citalopram-…

… not achieve symptom remission after 12 weeks of treatment (MDD-… should predict remission
after treatment with citalopram, a … treated with a 12-week course of combined citalopram and …

… Pharmacogenomic studies of remission and response after citalopram treatment based on
patients in the STAR*D level 1 sample included a genome-wide association analysis [ 12 ] …